Want to join the conversation?
$RBC said that 2Q16 results were generally in line with the company's expectations. Sales came in a little lighter than what company had planned, hurt by the slower start to the cooling season and further weakness in core industrial markets. $RBC added that organic sales were down in all three segments.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.